CANF Stock Analysis: Buy, Sell, or Hold?
CANF - Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares
$2.33
0.17 (7.87%)
▲
5d:
-0.85%
30d:
-32.27%
90d:
-18.25%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Apr 13, 2026
0d
Get Alerted When CANF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CANF shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CANF shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CANF is currently trading at $2.33, which is considered oversold relative to its 30-day fair value range of $2.59 to $3.58.
Technical Outlook: Technically, CANF is showing sideways momentum. Immediate support is located at $2.16, while resistance sits at $3.42. The stock is showing strong short-term momentum, up 7.9% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.00 (+243.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CANF is showing sideways momentum. Immediate support is located at $2.16, while resistance sits at $3.42. The stock is showing strong short-term momentum, up 7.9% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.00 (+243.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.59 -
$3.58
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Strong upward momentum (+7.9%)
- BULLISH: Trading 243.3% below Wall St target ($8.00)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.59 -
$3.58
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.16
Resistance Level
$3.42
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.63
Wall Street Target
$8.00
(+243.3%)
Revenue Growth (YoY)
-43.3%
Share & Embed Analysis
Last updated: September 13, 2026 9:45 PM ET
Data refreshes hourly during market hours. Next update: 10:45 PM
Data refreshes hourly during market hours. Next update: 10:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CANF showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
